ABT-737 is a potent, competitive BH3-mimetic inhibitor of Bcl-2, Bcl-xL, and Bcl-w. It affects intrinsic apoptotic signaling by displacing pro-apoptotic proteins like Bax and Bak, effectively promoting mitochondrial outer membrane permeabilization and cancer cell apoptosis.
ABT-737 IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for ABT-737 Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.